Trials / Completed
CompletedNCT05778786
Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 188 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treatment, 2-sequence, 2-period crossover study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acuvue Oasys 1 Day for Astigmatism | CONTROL |
| DEVICE | TRA100/TRA200 series toric contact lens with HEVL-blocking chromophore | TEST |
Timeline
- Start date
- 2023-03-13
- Primary completion
- 2023-05-24
- Completion
- 2023-05-24
- First posted
- 2023-03-21
- Last updated
- 2024-07-17
- Results posted
- 2024-07-17
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05778786. Inclusion in this directory is not an endorsement.